To help relieve excruciating anorectal symptoms from monkeypox, clinicians in the United States are prescribing tecovirimat, though in short supply, and recommending OTC treatments.
Investigators conducted a meta-analysis of randomized controlled trials on the effect of SGLT-2 inhibitors on patients with HFpEF.
Researchers identify treatment-specific and shared predictors for response to pharmacotherapies for ADHD among children.
Researchers compared the effects of amoxicillin with other broad-spectrum antibiotics on the risk for treatment failure and reinfection in children with uncomplicated acute otitis media.
Researchers investigated whether d-methylphenidate and guanfacine show promise as a combination treatment for ADHD in children.
The use of the CAGE-AID screening tool in the emergency department was linked to increased referral to an addiction recovery coach for treatment of substance use disorders.
May and June 2022 FDA approvals include treatments from alopecia areata, H. pylori, Crohn disease, plaque psoriasis, and Wilson disease.
Researchers examined other potential clinical benefits of molnupiravir versus placebo in a secondary analysis of data from a randomized phase 3 component of the MOVe-OUT trial.
Recent case reports suggest that some patients treated with Paxlovid may have a recurrence of COVID-19 symptoms 2 to 8 days after completing the 5-day course.
April 2022 FDA approvals include treatments for pediatric urinary tract infections, topical rosacea, vulvovaginal candidiasis, and various types of cancer.
